Lumenis 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Lumenis, Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    69139
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-2733-2014
  • 사례 시작날짜
    2014-08-15
  • 사례 출판 날짜
    2014-09-30
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2014-10-21
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Laser, ophthalmic - Product Code HQF
  • 원인
    Lumenis initiated a field-correction for the array laser link", ga-0006700 (sn xxyyzz) because the system may project an erroneous pattern display on the retina, which is different than the desired pattern.
  • 조치
    Lumenis sent a Safety Advisory Notice dated July 15, 2014, to all affected consignees. The letter identified the product, the problem, and the action to be taken by the consignee. Consignees were instructed that Lumenis would contact consignees to schedule a product update, to be completed at a convenient time. For questions consignees should call 801-656-2549. For questions regarding this recall call 801-656-2690.

Device

  • 모델명 / 제조번호(시리얼번호)
    All assembled units since product release, Part Number: GA-0006700.
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    No
  • 유통
    Worldwide Distribution - USA (nationwide) and Internationally to JAPAN, CHINA, and CANADA.
  • 제품 설명
    Array LaserLink, Manufactured by Lumenis, || The Array" LaserLink" is a laser system accessory intended for use in the treatment of ocular pathology. " For the Posterior Segment, the Array" LaserLink" is indicated for use in Retinal Photocoagulation and Panretinal Photocoagulation of Vascular and Structural Abnormalities of the Retina and Choroid including: " Proliferative and Severe and Very Severe Non-Proliferative Diabetic Retinopathy " Macular Edema associated with Proliferative or Non-Proliferative Diabetic Retinopathy " Choroidal Neovascularization " Retinal Neovascularization associated with Retinal Occlusive Disease (Branch Retinal Vein Occlusion; Central Retinal Vein Occlusion) " Macular Edema associated with Branch Retinal Vein Occlusion " Retinal Tears and Detachments And Anterior Segments as follows: " Iridotomy in Closed Angle Glaucoma " Trabeculoplasty in Open Angle Glaucoma
  • Manufacturer

Manufacturer

  • 제조사 주소
    Lumenis, Inc., 3959 W 1820 S, Salt Lake City UT 84104
  • 제조사 모회사 (2017)
  • Source
    USFDA